Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Infectious Respiratory Disease Diagnostics Market, by Product Type
1.4.2 Europe Infectious Respiratory Disease Diagnostics Market, by Application
1.4.3 Europe Infectious Respiratory Disease Diagnostics Market, by Sample Type
1.4.4 Europe Infectious Respiratory Disease Diagnostics Market, by Technology
1.4.5 Europe Infectious Respiratory Disease Diagnostics Market, by End Use
1.4.6 Europe Infectious Respiratory Disease Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansion
3.2.5 Approval & Trails:
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2020, Mar – 2022, Jun) Leading Players
Chapter 4. Europe Infectious Respiratory Disease Diagnostics Market by Product Type
4.1 Europe Consumables Market by Country
4.2 Europe Instruments Market by Country
4.3 Europe Infectious Respiratory Disease Diagnostics Market by Instruments Type
4.3.1 Europe Imaging Tests Market by Country
4.3.2 Europe Respiratory Measurement Devices Market by Country
4.3.3 Europe Others Market by Country
4.4 Europe Services Market by Country
Chapter 5. Europe Infectious Respiratory Disease Diagnostics Market by Application
5.1 Europe SARS/COVID 19 Market by Country
5.2 Europe Influenza Market by Country
5.3 Europe RSV (Respiratory Syncytial Virus) Market by Country
5.4 Europe Tuberculosis Market by Country
5.5 Europe Streptococcus Testing Market by Country
5.6 Europe Others Market by Country
Chapter 6. Europe Infectious Respiratory Disease Diagnostics Market by Sample Type
6.1 Europe Saliva Market by Country
6.2 Europe Anterior Nasal Region Market by Country
6.3 Europe Blood Market by Country
6.4 Europe Nasopharyngeal Swabs (NPS) Market by Country
6.5 Europe Others Market by Country
Chapter 7. Europe Infectious Respiratory Disease Diagnostics Market by Technology
7.1 Europe Molecular Diagnostics Market by Country
7.2 Europe Microbiology Market by Country
7.3 Europe Immunoassay Market by Country
7.4 Europe Others Market by Country
Chapter 8. Europe Infectious Respiratory Disease Diagnostics Market by End-use
8.1 Europe Diagnostic Laboratories Market by Country
8.2 Europe Hospitals Market by Country
8.3 Europe Physician Offices & Others Market by Country
Chapter 9. Europe Infectious Respiratory Disease Diagnostics Market by Country
9.1 Germany Infectious Respiratory Disease Diagnostics Market
9.1.1 Germany Infectious Respiratory Disease Diagnostics Market by Product Type
9.1.1.1 Germany Infectious Respiratory Disease Diagnostics Market by Instruments Type
9.1.2 Germany Infectious Respiratory Disease Diagnostics Market by Application
9.1.3 Germany Infectious Respiratory Disease Diagnostics Market by Sample Type
9.1.4 Germany Infectious Respiratory Disease Diagnostics Market by Technology
9.1.5 Germany Infectious Respiratory Disease Diagnostics Market by End-use
9.2 UK Infectious Respiratory Disease Diagnostics Market
9.2.1 UK Infectious Respiratory Disease Diagnostics Market by Product Type
9.2.1.1 UK Infectious Respiratory Disease Diagnostics Market by Instruments Type
9.2.2 UK Infectious Respiratory Disease Diagnostics Market by Application
9.2.3 UK Infectious Respiratory Disease Diagnostics Market by Sample Type
9.2.4 UK Infectious Respiratory Disease Diagnostics Market by Technology
9.2.5 UK Infectious Respiratory Disease Diagnostics Market by End-use
9.3 France Infectious Respiratory Disease Diagnostics Market
9.3.1 France Infectious Respiratory Disease Diagnostics Market by Product Type
9.3.1.1 France Infectious Respiratory Disease Diagnostics Market by Instruments Type
9.3.2 France Infectious Respiratory Disease Diagnostics Market by Application
9.3.3 France Infectious Respiratory Disease Diagnostics Market by Sample Type
9.3.4 France Infectious Respiratory Disease Diagnostics Market by Technology
9.3.5 France Infectious Respiratory Disease Diagnostics Market by End-use
9.4 Russia Infectious Respiratory Disease Diagnostics Market
9.4.1 Russia Infectious Respiratory Disease Diagnostics Market by Product Type
9.4.1.1 Russia Infectious Respiratory Disease Diagnostics Market by Instruments Type
9.4.2 Russia Infectious Respiratory Disease Diagnostics Market by Application
9.4.3 Russia Infectious Respiratory Disease Diagnostics Market by Sample Type
9.4.4 Russia Infectious Respiratory Disease Diagnostics Market by Technology
9.4.5 Russia Infectious Respiratory Disease Diagnostics Market by End-use
9.5 Spain Infectious Respiratory Disease Diagnostics Market
9.5.1 Spain Infectious Respiratory Disease Diagnostics Market by Product Type
9.5.1.1 Spain Infectious Respiratory Disease Diagnostics Market by Instruments Type
9.5.2 Spain Infectious Respiratory Disease Diagnostics Market by Application
9.5.3 Spain Infectious Respiratory Disease Diagnostics Market by Sample Type
9.5.4 Spain Infectious Respiratory Disease Diagnostics Market by Technology
9.5.5 Spain Infectious Respiratory Disease Diagnostics Market by End-use
9.6 Italy Infectious Respiratory Disease Diagnostics Market
9.6.1 Italy Infectious Respiratory Disease Diagnostics Market by Product Type
9.6.1.1 Italy Infectious Respiratory Disease Diagnostics Market by Instruments Type
9.6.2 Italy Infectious Respiratory Disease Diagnostics Market by Application
9.6.3 Italy Infectious Respiratory Disease Diagnostics Market by Sample Type
9.6.4 Italy Infectious Respiratory Disease Diagnostics Market by Technology
9.6.5 Italy Infectious Respiratory Disease Diagnostics Market by End-use
9.7 Rest of Europe Infectious Respiratory Disease Diagnostics Market
9.7.1 Rest of Europe Infectious Respiratory Disease Diagnostics Market by Product Type
9.7.1.1 Rest of Europe Infectious Respiratory Disease Diagnostics Market by Instruments Type
9.7.2 Rest of Europe Infectious Respiratory Disease Diagnostics Market by Application
9.7.3 Rest of Europe Infectious Respiratory Disease Diagnostics Market by Sample Type
9.7.4 Rest of Europe Infectious Respiratory Disease Diagnostics Market by Technology
9.7.5 Rest of Europe Infectious Respiratory Disease Diagnostics Market by End-use
Chapter 10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent strategies and developments:
10.1.5.1 Product Launches and Product Expansions:
10.1.5.2 Acquisition and Mergers:
10.1.6 SWOT Analysis
10.2 Becton, Dickinson and Company
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Partnerships, Collaborations, and Agreements:
10.2.5.2 Product Launches and Product Expansions:
10.2.6 SWOT Analysis
10.3 Siemens Healthineers AG (Siemens AG)
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expense
10.3.5 Recent strategies and developments:
10.3.5.1 Partnerships, Collaborations, and Agreements:
10.3.5.2 Acquisitions and Mergers:
10.3.5.3 Geographical Expansions:
10.3.6 SWOT Analysis
10.4 Thermo Fisher Scientific, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Partnerships, Collaborations, and Agreements:
10.4.5.2 Product Launches and Product Expansions:
10.5 Koninklijke Philips N.V.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Partnerships, Collaborations, and Agreements:
10.6 F. Hoffmann-La Roche Ltd.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.6.5 Recent strategies and developments:
10.6.5.1 Product Launches and Product Expansions:
10.7 Qiagen N.V.
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Regional Analysis
10.7.4 Research & Development Expense
10.7.5 Recent strategies and developments:
10.7.5.1 Product Launches and Product Expansions:
10.8 Bio-Rad laboratories, Inc.
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Research & Development Expenses
10.8.5 Recent strategies and developments:
10.8.5.1 Product Launches and Product Expansions:
10.9 Danaher Corporation
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental and Regional Analysis
10.9.4 Research & Development Expense
10.9.5 Recent strategies and developments:
10.9.5.1 Acquisitions and Mergers:
10.10. Quidel Corporation
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Regional Analysis
10.10.4 Research & Development Expense
10.10.5 Recent strategies and developments:
10.10.5.1 Approvals & Trails:
Unique Offerings 